P Mustajoki
Overview
Explore the profile of P Mustajoki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
876
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Niskanen L, Laaksonen D, Punnonen K, Mustajoki P, Kaukua J, Rissanen A
Diabetes Obes Metab
. 2004 Apr;
6(3):208-15.
PMID: 15056129
Background: Mild hypoandrogenism in men, usually defined by low levels of testosterone, is a peculiar feature of abdominal obesity that independently predicts the development of insulin resistance and diabetes mellitus....
2.
Kaukua J, Pekkarinen T, Sane T, Mustajoki P
Int J Obes Relat Metab Disord
. 2003 Sep;
27(10):1233-41.
PMID: 14513072
Objective: To study health-related quality of life (HRQL) in a clinically selected sample of obese outpatients. Design: A single-strand before and after study with 2-y follow-up after treatment comprising 10...
3.
Kaukua J, Pekkarinen T, Sane T, Mustajoki P
Int J Obes Relat Metab Disord
. 2003 Aug;
27(9):1072-80.
PMID: 12917713
Objective: To study health-related quality of life (HRQL) in a clinically selected sample obese outpatients. Design: A single-strand before and after study with 2-y follow-up after treatment comprising 10 weeks...
4.
Schalin-Jantti C, Valli-Jaakola K, Oksanen L, Martelin E, Laitinen K, Krusius T, et al.
Int J Obes Relat Metab Disord
. 2003 Jan;
27(1):70-4.
PMID: 12532156
Background: Linkage and knock-out mice studies suggest that the melanocortin-3-receptor (MC3R) is a candidate gene for obesity. Objective: To evaluate whether MC3R mutations underlie morbid obesity. Subjects And Methods: MC3R...
5.
Mustajoki P, Pekkarinen T
Obes Rev
. 2002 Jul;
2(1):61-72.
PMID: 12119638
Very low energy diets (VLEDs) are defined as diets which contain energy levels of less than 3.4 MJ (800 kcal) per day and contain daily allowances of all essential nutritional...
6.
Kaukua J, Pekkarinen T, Sane T, Mustajoki P
Int J Obes Relat Metab Disord
. 2002 Jun;
26(4):487-95.
PMID: 12075575
Objective: To study health-related quality of life responses to marked weight loss in WHO Class II-III (body mass index (BMI) > or = 35 kg/m2) obese men. Design: An 8...
7.
8.
Tiitinen A, Rissanen A, Mustajoki P
Duodecim
. 2002 Jan;
116(5):495-501.
PMID: 11787102
No abstract available.
9.
Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study
Madsbad S, Kilhovd B, Lager I, Mustajoki P, Dejgaard A
Diabet Med
. 2001 Jul;
18(5):395-401.
PMID: 11472451
Aims: To evaluate the long-term effectiveness and safety of repaglinide, a novel prandial glucose regulator, in comparison with glipizide in the treatment of patients with Type 2 diabetes. Methods: Diet...
10.